Mark Birkenbach

Title: Mark Birkenbach: Innovator in Epstein Barr Virus Research

Introduction

Mark Birkenbach is a notable inventor based in Tinley Park, IL (US). He has made significant contributions to the field of medical research, particularly in the study of the Epstein Barr virus. With a total of 4 patents to his name, his work has implications for understanding and detecting this virus.

Latest Patents

Birkenbach's latest patents focus on antibodies that bind to proteins induced by the Epstein Barr virus. These inventions include DNA segments coding for EBI 1, EBI 2, or EBI 3 polypeptides, as well as recombinant DNA molecules and cells containing these molecules. His patents also cover antisense constructs, antibodies with binding affinity to EBI polypeptides, and methods for detecting the presence of the Epstein Barr virus in samples. Additionally, he has developed kits that contain nucleic acid probes or antibodies for this purpose.

Career Highlights

Mark Birkenbach is affiliated with Brigham and Women's Hospital, Inc., where he conducts his research. His work has been instrumental in advancing the understanding of Epstein Barr virus-induced genes and their potential applications in medical diagnostics and therapeutics.

Collaborations

Some of his notable coworkers include Elliot Kieff and Elliott D Kieff, who have collaborated with him on various research projects related to the Epstein Barr virus.

Conclusion

Mark Birkenbach's innovative work in the field of Epstein Barr virus research has led to significant advancements in medical science. His patents and collaborations continue to contribute to the understanding and detection of this virus, showcasing the importance of his contributions to the field.